PDGFRB and hematologic disorder: Mutations involving up-regulation of PDGF and/or PDGFR, as well as PDGFR-dependent growth stimulation, have been documented in a number of solid tumors and hematological malignancies, suggesting a likely role of this pathway in carcinogenesis[10,15].